These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9153265)

  • 1. Grapefruits and drugs: when is statistically significant clinically significant?
    Abernethy DR
    J Clin Invest; 1997 May; 99(10):2297-8. PubMed ID: 9153265
    [No Abstract]   [Full Text] [Related]  

  • 2. On the assessment of effects of food on the pharmacokinetics of drugs in early development.
    Li Z; Vachharajani NN; Krishna R
    Biopharm Drug Dispos; 2002 May; 23(4):165-71. PubMed ID: 12015791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisapride (Prepulsid): interactions with grapefruit and drugs.
    Morawiecka I
    CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics. SNP-ing drugs to size.
    Gura T
    Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochromes in psychopharmacology.
    von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral erythromycin and the risk of sudden death.
    Amory JK; Amory DW
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
    [No Abstract]   [Full Text] [Related]  

  • 7. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
    Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
    J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP3A genetics in drug metabolism.
    Eichelbaum M; Burk O
    Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
    Chiou WL; Jeong HY; Wu TC; Ma C
    Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythromycin breath test.
    Watkins PB
    Clin Pharmacol Ther; 2000 May; 67(5):577-8. PubMed ID: 10824637
    [No Abstract]   [Full Text] [Related]  

  • 12. Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
    Zhu B; Ou-Yang DS; Cheng ZN; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2001 Jul; 22(7):634-8. PubMed ID: 11749829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grapefruit juice activates P-glycoprotein-mediated drug transport.
    Soldner A; Christians U; Susanto M; Wacher VJ; Silverman JA; Benet LZ
    Pharm Res; 1999 Apr; 16(4):478-85. PubMed ID: 10227700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin-layer chromatographic analysis of human CYP3A-catalyzed testosterone 6 beta-hydroxylation.
    Waxman DJ; Chang TK
    Methods Mol Biol; 1998; 107():153-61. PubMed ID: 14577225
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
    Ma B; Prueksaritanont T; Lin JH
    Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of disease on expression and regulation of CYPs.
    Farrell G
    Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
    Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
    Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
    Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine has a minor effect on cyclosporine metabolism.
    McGregor DO; Bailey RR; Robson RA
    Clin Nephrol; 1997 Nov; 48(5):336. PubMed ID: 9403222
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
    Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
    Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.